Hemochromatosis: Genetics and pathophysiology

Annual Review of Medicine

Volumn 57, Issue , 2006, Pages 331-347

  Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Ferroportin; Hepcidin; HFE; Iron; Penetrance

Indexed keywords

FERROPORTIN 1; HEMOJUVELIN; HEPCIDIN; TRANSFERRIN RECEPTOR 2;

GENE MUTATION; GENETIC DISORDER; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON STORAGE; PRIORITY JOURNAL; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MEMBRANE PROTEINS; PENETRANCE; RECEPTORS, TRANSFERRIN;

EID: 33144456592     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.57.121304.131310     Document Type: Review

References (111)

1. Cullen LM, Anderson GJ, Ramm GA, et al. 1999. Genetics of hemochromatosis. Annu. Rev. Med. 50:87-98
2. 1a. Sheldon JH. 1935. Haemochromatosis. London: Oxford Univ. Press. 382 pp.
3. MacDonald RA. 1963. Idiopathic hemochromatosis. Genetic or acquired? Arch. Intern. Med. 112:82-88
4. 2a. Simon M, Pawlotsky Y, Bourel M, et al. 1975. Hémochromatose idiopathique: maladie associée à l'antigène tissulaire. Nouv. Presse Med. 4:1432
5. Simon M, Bourel R, Fauchet R, et al. 1976. Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 17:332-34
6. Feder JN, Gnirke A, Thomas W, et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-408
7. Papanikolaou G, Samuels ME, Ludwig EH, et al. 2004. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36:77-82
8. Roetto A, Papanikolaou G, Politou M, et al. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33:21-22
9. Pietrangelo A. 2004. The ferroportin disease. Blood Cells Mol. Dis. 32:131-38
10. Beutler E, Barton JC, Felitti VJ, et al. 2003. Ferroportin (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol. Dis. 31:305-9
11. Camaschella C, Roetto A, Cali A, et al. 2000. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25:14-15
12. Fleming MD, Trenor CC 3rd, Su MA, et al. 1997. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16:383-86
13. Fleming MD, Romano MA, Su MA, et al. 1998. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. USA 95:1148-53
14. Mims MP, Guan YL, Pospisilova D, et al. 2005. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105:1337-42
15. Beutler E. 1980. Iron. In Modern Nutrition in Health and Disease, ed. RS Goodhart, ME Shils, pp. 324-54. New York: Lea and Febiger
16. Uc A, Stokes JB, Britigan BE. 2004. Heme transport exhibits polarity in Caco-2 cells: evidence for an active and membrane protein-mediated process. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G1150-G1157
17. Weintraub LR, Weinstein MB, Huser H, et al. 1968. Absorption of hemoglobin iron: the role of a heme-splitting substance in the intestinal mucosa. J. Clin. Invest. 47:531-39
18. Gunshin H, Mackenzie B, Berger UV, et al. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388:482-88
19. Latunde-Dada GO, Van der Westhuizen J, Vulpe CD, et al. 2002. Molecular and functional roles of duodenal cytochrome B (dcytb) in iron metabolism. Blood Cells Mol. Dis. 29:356-60
20. Thomas C, Oates PS. 2004. Ferroportin/IREG-1/MTP-1/SLC40A1 modulates the uptake of iron at the apical membrane of enterocytes. Gut 53:44-49
21. Simovich M, Hainsworth LN, Fields PA, et al. 2003. Localization of the iron transport proteins mobilferrin and DMT-1 in the duodenum: the surprising role of mucin. Am. J. Hematol. 74:32-45
22. Conrad ME, Umbreit JN. 2002. Pathways of iron absorption. Blood Cells Mol. Dis. 29:336-55
23. Beutler E. 2002. History of iron in medicine. Blood Cells Mol. Dis. 29:297-308
24. Vulpe CD, Kuo YM, Murphy TL, et al. 1999. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21:195-99
25. Pigeon C, Ilyin G, Courselaud B, et al. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276:7811-19
26. Nicolas G, Bennoun M, Devaux I, et al. 2001. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98:8780-85
27. Lee P, Peng H, Gelbart T, et al. 2005. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. USA 102:1906-10
28. Nemeth E, Rivera S, Gabayan V, et al. 2004. EL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113:1271-76
29. Nicolas G, Chauvet C, Viatte L, et al. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110:1037-44
30. Nicolas G, Viatte L, Bennoun M, et al. 2002. Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29:327-35
31. Ganz T. 2004. Is TfR2 the iron sensor? Blood 104:3839-40
32. Johnson MB, Enns CA. 2004. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104:4287-93
33. Nemeth E, Turtle MS, Powelson J, et al. 2004. Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-93
34. Ahmad KA, Ahmann JR, Migas MC, et al. 2002. Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29:361-66
35. Kawabata H, Fleming RE, Gui D, et al. 2005. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105:376-81
36. Nemeth E, Roetto A, Garozzo G, et al. 2005. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105:1803-6
37. Nemeth E, Valore EV, Territo M, et al. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101:2461-63
38. Ganz T. 2003. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783-88
39. Donovan A, Brownlie A, Zhou Y, et al. 2000. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403:776-81
40. Mok H, Jelinek J, Pai S, et al. 2004. Disruption of ferroportin 1 regulation causes dynamic alterations in iron homeostasis and erythropoiesis in polycythaemia mice. Development 131:1859-68
41. Lucotte G. 2001. Frequency analysis and allele map in favor of the Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol. Dis. 27:549-56
42. Ajioka RS, Jorde LB, Gruen JR, et al. 1997. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am. J. Hum. Genet. 60:1439-47
43. Toomajian C, Ajioka RS, Jorde LB, et al. 2003. A method for detecting recent se-lection in the human genome from allele age estimates. Genetics 165:287-97
44. Beutler E. 1997. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 349:296-97
45. Beutler E, Gelbart T, West C, et al. 1996. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol. Dis. 22:187-94
46. Mura C, Raguenes O, Ferec C. 1999. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood 93:2502-5
47. Beutler E, Felitti V, Gelbart T, et al. 2000. The effect of HFE genotypes in patients attending a health appraisal clinic. Ann. Intern. Med. 133:329-37
48. Beutler E, Felitti VJ, Ho NJ, et al. 1999. Commentary: An HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors by Naveen Arya, Subrata Chakrabrati, Robert A. Hegele, Paul C. Adams. Blood Cells Mol. Dis. 25:358-60
49. Beutler L, Beutler E. 2004. Hematologically important mutations: hemochromatosis. Blood Cells Mol. Dis. 33:40-44
50. Beutler E, Gelbart T. 2000. A common intron 3 mutation (IVS3-48c → g) leads to misdiagnosis of the c.845G → A (C282Y) HFE gene mutation. Blood Cells Mol. Dis. 26:229-33
51. Jeffrey GP, Chakrabarti S, Regele RA, et al. 1999. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis. Nat. Genet. 22:325-26
52. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. 1999. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat. Genet. 23:271
53. Noll WW, Belloni DR, Stenzel TT, et al. 1999. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. Nat. Genet. 23:271-72
54. 51a. Parkkila S, Waheed A, Britton RS, et al. 1997. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl. Acad. Sci. USA 94:13198-202
55. 51b. Lebrón JA, Bennett MJ, Vaughn DE, et al. 1998. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93:111-23
56. 51c. Davies PS, Enns CA. 2004. Expression of the hereditary hemochromatosis protein HFE increases ferritin levels by inhibiting iron export in HT29 cells. J. Biol. Chem. 279:25085-92
57. 51d. Lucotte G, Dieterlen F. 2003. A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation? Blood Cells Mol. Dis. 31:262-67
58. Roetto A, Totaro A, Piperno A, et al. 2001. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97:2555-60
59. Aguilar-Martinez P, Esculie-Coste C, Bismuth M, et al. 2001. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Blood Cells Mol. Dis. 27:290-93
60. Barton EH, West PA, Rivers CA, et al. 2001. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload. Blood Cells Mol. Dis. 27:279-84
61. De Gobbi M, Daraio F, Oberkanins C, et al. 2003. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload. Haematologica 88:396-401
62. Lee PL, Halloran C, West C, et al. 2001. Mutation analysis of the transferrin receptor-2 gene in patients with iron overload. Blood Cells Mol. Dis. 27:285-89
63. Lee PL, Gelbart T, West C, et al. 2002. Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol. Dis. 29:471-87
64. Camaschella C, Roetto A, De Gobbi M. 2002. Juvenile hemochromatosis. Semin. Hematol. 39:242-48
65. 58a. Lin L, Goldberg YP, Ganz T. 2005. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106:2884-89
66. Robson KJ, Merryweather-Clarke AT, Cadet E, et al. 2004. Recent advances in understanding haemochromatosis: a transition state. J. Med. Genet. 41:721-30
67. Pissia M, Polonifi K, Politou M, et al. 2004. Prevalence of the G320V mutation of the HJV gene, associated with juvenile hemochromatosis, in Greece. Haematologica 89:742-43
68. Janosi A, Andrikovics H, Vas K, et al. 2005. Homozygosity for a novel nonsense mutation (G66X) of the HJV gene causes severe juvenile hemochromatosis with fatal cardiomyopathy. Blood 105:432
69. Huang FW, Rubio-Aliaga I, Kushner JP, et al. 2004. Identification of a novel mutation (C321X) in HJV. Blood 104:2176-77
70. Filali M, Le Jeunne C, Durand E, et al. 2004. Juvenile hemochromatosis HJV-related revealed by cardiogenic shock. Blood Cells Mol. Dis. 33:120-24
71. Lee PL, Beutler E, Rao SV, et al. 2004. Genetic abnormalities and juvenile hemochromatosis mutations of the HJV gene encoding hemojuvelin. Blood 103:4669-71
72. Lanzara C, Roetto A, Daraio F, et al. 2004. The spectrum of hemojuvelin gene mutations in 1q-linked juvenile hemochromatosis. Blood 103:4317-21
73. Daraio F, Ryan E, Gleeson F, et al. 2005. Juvenile hemochromatosis due to G320V/Q116X compound heterozygosity of hemojuvelin in an Irish patient. Blood Cells Mol. Dis. In press
74. Lee PL, Barton JC, Brandhagen D, et al. 2004. Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis. Br. J. Haematol. 127:224-29
75. Biasiotto G, Roetto A, Daraio F, et al. 2004. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol. Dis. 33:338-43
76. Le Gac G, Scotet V, Ka C, et al. 2004. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum. Mol. Genet. 13:1913-18
77. Wallace DF, Dixon JL, Ramm GA, et al. 2005. Hemojuvelin (HJV)-associated hemochromatosis: analysis of HJV and HFE mutations and iron overload in three families. Haematologica 90:254-55
78. Barton JC, Rivers CA, Niyongere S, et al. 2004. Allele frequencies of hemojuvelin gene (HJV) I222N and G320V missense mutations in white and African American subjects from the general Alabama popu-lation. BMC Med. Genet. 5:29
79. Delatycki M, Allen K, Gow P, et al. 2004. A homozygous HAMP mutation in a multiply consanguineous family with pseudo-dominant juvenile hemochromatosis. Clin. Genet. 65:378-83
80. Majore S, Binni F, Pennese A, et al. 2004. HAMP gene mutation C.208T > C (p.C70R) identified in an Italian patient with severe hereditary hemochromatosis. Hum. Mutat. 23:400
81. Matthes T, Aguilar-Martinez P, Pizzi-Bosman L, et al. 2004. Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5′UTR of the HAMP gene. Blood 104:2181-83
82. Biasiotto G, Belloli S, Rugged G, et al. 2003. Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin. Chem. 49:1981-88
83. Jacolot S, Le Gac G, Scotet V, et al. 2004. HAMP as a modifier gene that increases the phenotypic expression of the HFE p.C282Y homozygous genotype. Blood 103:2835-40
84. Merryweather-Clarke AT, Cadet E, Bomford A, et al. 2003. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet. 12:2241-47
85. Nicolas G, Andrews NC, Kahn A, et al. 2004. Hepcidin, a candidate modifier of the hemochromatosis phenotype in mice. Blood 103:2841-43
86. Schimanski LM, Drakesmith H, Merryweather-Clarke AT, et al. 2005. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis- associated FPN mutations. Blood 105:4096-102
87. Cazzola M, Cremonesi L, Papaioannou M, et al. 2002. Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (SLC11A3). Br. J. Haematol. 119:539-46
88. Devalia V, Carter K, Walker AP, et al. 2002. Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). Blood 100:695-97
89. Roetto A, Merryweather-Clarke AT, Daraio F, et al. 2002. A valine deletion of ferroportin 1: a common mutation in hemochromatosis type 4? Blood 100:733-34
90. Gordeuk VR, Caleffi A, Corradini E, et al. 2003. Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol. Dis. 31:299-304
91. Hannuksela J, Niemela O, Leppilampi M, et al. 2003. Clinical utility and outcome of HFE-genotyping in the search for hereditary hemochromatosis. Clin. Chim. Acta 331:61-62
92. Asberg A, Tretli S, Hveem K, et al. 2002. Benefit of population-based screening for phenotypic hemochromatosis in young men. Scand. J. Gastroenterol. 37:1212-19
93. Beutler E, Felitti VJ, Koziol JA, et al. 2002. Penetrance of the 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211-18
94. Adams PC, Kertesz AE, McLaren CE, et al. 2000. Population screening for hemochromatosis: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors. Hepatology 31:1160-64
95. Deugnier Y, Jouanolle AM, Chaperon J, et al. 2002. Gender-specific phenotypic expression and screening strategies in C282 Y-linked haemochromatosis: a study of 9396 French people. Br. J. Haematol. 118:1170-78
96. Olsson KS, Säfwenberg J, Ritter B. 1988. The effect of iron fortification of the diet on clinical iron overload in the general population. Ann. NY Acad. Sci. 526:290-300
97. Bradley LA, Haddow JE, Palomaki GE. 1996. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J. Med. Screen. 3:171-77
98. Shukla A, Agarwal KN, Chansuria JPN, et al. 1989. Effect of latent iron deficiency on 5-hydroxytryptamine metabolism in rat brain. J. Neurochem. 52:730-35
99. Andersen RV, Tybjaerg-Hansen A, Appleyard M, et al. 2004. Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:2914-19
100. Olynyk JK, Hagan SE, Cullen DJ, et al. 2004. Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study. Mayo Clin. Proc. 79:309-13
101. Waalen J, Felitti V, Gelbart T, et al. 2002. Prevalence of hemochromatosis-related symptoms in homozygotes for the C282Y mutation of the HFE gene. Mayo Clin. Proc. 77:522-30
102. Waalen J, Felitti VJ, Gelbart T, et al. 2002. Penetrance of hemochromatosis. Blood Cells Mol. Dis. 29:418-32
103. Åsberg A, Hveem K, Thorstensen K, et al. 2001. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand. J. Gastroenterol. 36:1108-15
104. Åsberg A, Hveem K, Kruger O, et al. 2002. Persons with screening-detected haemochromatosis: as healthy as the general population? Scand. J. Gastroenterol. 37:719-24
105. Bulaj ZJ, Ajioka RS, Phillips JD, et al. 2000. Disease-related conditions in relatives of patients with hemochromatosis. N. Engl. J. Med. 343:1529-35
106. Olynyk JK, Cullen DJ, Aquilia S, et al. 1999. A population-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 341:718-24
107. Cortes-Espinosa T, Mondragon-Sanchez R, Hurtado-Andrade H, et al. 1997. Hepatocellular carcinoma and hepatic cirrhosis in Mexico: a 25 year necroscopy review. Hepatogastroenterology 44:1401-3
108. Bartoloni SO, Giannini A, Napoli P. 1984. Hepatocellular carcinoma and cirrhosis: a review of their relative incidence in a 25-year period in the Florence area. Hepatogastroenterology 31:215-17
109. Burnett RA, Patrick RS, Spilg WG, et al. 1978. Hepatocellular carcinoma and hepatic cirrhosis in the west of Scotland: a 25-year necropsy review. J. Clin. Pathol 31:108-10
110. Ajioka RS, Kushner JP. 2003. Rebuttal to Beutler. Blood 101:3358
111. Waalen J, Nordestgaard BG, Beutler E. 2005. The penetrance of hereditary hemochromatosis. Best Pract. Res. Clin. Haematol. 18:203-20